US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 90.510
  • +0.640+0.71%
Close Oct 1 16:00 ET
4.34BMarket Cap-13755P/E (TTM)

Axsome Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
86.65%87.17M
-20.70%75M
440.80%270.6M
193.50%71.53M
243.07%57.79M
429.48%46.7M
94.58M
50.04M
24.37M
16.85M
Operating revenue
86.65%87.17M
-20.70%75M
440.80%270.6M
193.50%71.53M
243.07%57.79M
429.48%46.7M
--94.58M
--50.04M
--24.37M
--16.85M
Cost of revenue
75.15%8.06M
-16.66%6.3M
401.44%26.07M
222.04%7.38M
239.50%6.53M
367.85%4.6M
7.56M
5.2M
2.29M
1.92M
Gross profit
87.91%79.11M
-21.05%68.7M
445.36%244.54M
190.54%64.15M
243.53%51.26M
437.21%42.1M
87.02M
44.84M
22.08M
14.92M
Operating expense
53.30%155M
46.85%137.39M
93.12%427.44M
53.24%119.22M
97.93%113.56M
111.17%101.11M
144.34%93.56M
77.49%221.34M
138.58%77.8M
71.75%57.38M
Selling and administrative expenses
31.19%103.55M
33.40%98.97M
102.90%323.12M
41.16%86.81M
103.43%83.19M
153.32%78.94M
188.64%74.19M
138.96%159.25M
226.66%61.5M
102.17%40.89M
Research and development costs
142.23%49.85M
106.99%36.83M
69.02%97.94M
109.64%30.8M
93.37%28.77M
30.33%20.58M
41.38%17.79M
-0.20%57.95M
6.61%14.69M
12.87%14.88M
Depreciation amortization depletion
0.06%1.59M
1.08%1.59M
54.02%6.38M
0.00%1.61M
0.00%1.61M
71.60%1.59M
--1.57M
--4.14M
--1.61M
--1.61M
-Depreciation and amortization
0.06%1.59M
1.08%1.59M
54.02%6.38M
0.00%1.61M
0.00%1.61M
71.60%1.59M
--1.57M
--4.14M
--1.61M
--1.61M
Operating profit
-28.61%-75.89M
-950.90%-68.69M
-3.63%-182.91M
1.17%-55.07M
-46.75%-62.3M
-47.36%-59M
82.93%-6.54M
-41.53%-176.5M
-70.87%-55.72M
-27.08%-42.45M
Net non-operating interest income expense
52.42%-1.3M
52.21%-1.08M
12.02%-6.45M
46.94%-702K
68.60%-757K
-20.96%-2.73M
-68.58%-2.26M
-28.77%-7.34M
3.29%-1.32M
-63.40%-2.41M
Non-operating interest expense
-52.42%1.3M
-52.21%1.08M
-12.02%6.45M
-46.94%702K
-68.60%757K
20.96%2.73M
68.58%2.26M
28.77%7.34M
-3.29%1.32M
63.40%2.41M
Other net income (expense)
64.32%-2.16M
771.60%1.41M
-1,383.26%-48.92M
-928.74%-43.21M
328.57%180K
-803.84%-6.05M
162K
-3.3M
-4.2M
42K
Special income (charges)
64.32%-2.16M
771.60%1.41M
-1,383.26%-48.92M
-928.74%-43.21M
328.57%180K
-803.84%-6.05M
--162K
---3.3M
---4.2M
--42K
-Less：Restructuring and merger&acquisition
-64.32%2.16M
-771.60%-1.41M
1,383.26%48.92M
928.74%43.21M
-328.57%-180K
803.84%6.05M
---162K
--3.3M
--4.2M
---42K
Income before tax
-17.05%-79.35M
-691.35%-68.36M
-27.33%-238.28M
-61.62%-98.98M
-40.28%-62.88M
-63.59%-67.79M
78.20%-8.64M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
Income tax
0
0
960K
-325K
-678K
-617K
2.58M
0
0
0
Net income
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
Net income continuous Operations
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
Minority interest income
Net income attributable to the parent company
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
Basic earnings per share
-8.44%-1.67
-453.85%-1.44
-14.57%-5.27
-47.52%-2.08
-23.36%-1.32
-45.28%-1.54
74.76%-0.26
-32.56%-4.6
-56.67%-1.41
-15.05%-1.07
Diluted earnings per share
-8.44%-1.67
-453.85%-1.44
-14.57%-5.27
-47.52%-2.08
-23.36%-1.32
-45.28%-1.54
74.76%-0.26
-32.56%-4.6
-56.67%-1.41
-15.05%-1.07
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 86.65%87.17M-20.70%75M440.80%270.6M193.50%71.53M243.07%57.79M429.48%46.7M94.58M50.04M24.37M16.85M
Operating revenue 86.65%87.17M-20.70%75M440.80%270.6M193.50%71.53M243.07%57.79M429.48%46.7M--94.58M--50.04M--24.37M--16.85M
Cost of revenue 75.15%8.06M-16.66%6.3M401.44%26.07M222.04%7.38M239.50%6.53M367.85%4.6M7.56M5.2M2.29M1.92M
Gross profit 87.91%79.11M-21.05%68.7M445.36%244.54M190.54%64.15M243.53%51.26M437.21%42.1M87.02M44.84M22.08M14.92M
Operating expense 53.30%155M46.85%137.39M93.12%427.44M53.24%119.22M97.93%113.56M111.17%101.11M144.34%93.56M77.49%221.34M138.58%77.8M71.75%57.38M
Selling and administrative expenses 31.19%103.55M33.40%98.97M102.90%323.12M41.16%86.81M103.43%83.19M153.32%78.94M188.64%74.19M138.96%159.25M226.66%61.5M102.17%40.89M
Research and development costs 142.23%49.85M106.99%36.83M69.02%97.94M109.64%30.8M93.37%28.77M30.33%20.58M41.38%17.79M-0.20%57.95M6.61%14.69M12.87%14.88M
Depreciation amortization depletion 0.06%1.59M1.08%1.59M54.02%6.38M0.00%1.61M0.00%1.61M71.60%1.59M--1.57M--4.14M--1.61M--1.61M
-Depreciation and amortization 0.06%1.59M1.08%1.59M54.02%6.38M0.00%1.61M0.00%1.61M71.60%1.59M--1.57M--4.14M--1.61M--1.61M
Operating profit -28.61%-75.89M-950.90%-68.69M-3.63%-182.91M1.17%-55.07M-46.75%-62.3M-47.36%-59M82.93%-6.54M-41.53%-176.5M-70.87%-55.72M-27.08%-42.45M
Net non-operating interest income expense 52.42%-1.3M52.21%-1.08M12.02%-6.45M46.94%-702K68.60%-757K-20.96%-2.73M-68.58%-2.26M-28.77%-7.34M3.29%-1.32M-63.40%-2.41M
Non-operating interest expense -52.42%1.3M-52.21%1.08M-12.02%6.45M-46.94%702K-68.60%757K20.96%2.73M68.58%2.26M28.77%7.34M-3.29%1.32M63.40%2.41M
Other net income (expense) 64.32%-2.16M771.60%1.41M-1,383.26%-48.92M-928.74%-43.21M328.57%180K-803.84%-6.05M162K-3.3M-4.2M42K
Special income (charges) 64.32%-2.16M771.60%1.41M-1,383.26%-48.92M-928.74%-43.21M328.57%180K-803.84%-6.05M--162K---3.3M---4.2M--42K
-Less：Restructuring and merger&acquisition -64.32%2.16M-771.60%-1.41M1,383.26%48.92M928.74%43.21M-328.57%-180K803.84%6.05M---162K--3.3M--4.2M---42K
Income before tax -17.05%-79.35M-691.35%-68.36M-27.33%-238.28M-61.62%-98.98M-40.28%-62.88M-63.59%-67.79M78.20%-8.64M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M
Income tax 00960K-325K-678K-617K2.58M000
Net income -18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M
Net income continuous Operations -18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M
Minority interest income
Net income attributable to the parent company -18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M
Basic earnings per share -8.44%-1.67-453.85%-1.44-14.57%-5.27-47.52%-2.08-23.36%-1.32-45.28%-1.5474.76%-0.26-32.56%-4.6-56.67%-1.41-15.05%-1.07
Diluted earnings per share -8.44%-1.67-453.85%-1.44-14.57%-5.27-47.52%-2.08-23.36%-1.32-45.28%-1.5474.76%-0.26-32.56%-4.6-56.67%-1.41-15.05%-1.07
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data